EnPlusOne is enabling the future of RNA and RNA solutions. Its ezRNA™ synthesis platform is a revolutionary innovation that can incorporate a diverse array of nucleotide modifications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/30/22 | $12,000,000 | Seed |
Breakout Ventures Coatue Management Northpond Ventures | undisclosed |
